icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Sofosbuvir Plus Ribavirin, an Interferon-Free Regimen, in the Treatment of Treatment-Naïve and -Experienced Patients With Chronic Genotype 4 HCV Infection
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Peter J. Ruane,1 Dani Ain,1 Raymond Meshrekey,1 Joseph Riad,1 Richard Stryker,1 Mina Soliman,1 Sam Mikhail,1 Peter R. Wolfe,1 Kathryn Kersey,2 Brian Doehle,2 Deyuan Jiang,2 William T. Symonds2
1Ruane Medical and Liver Health Institute, Los Angeles, California, USA; 2Gilead Sciences, Inc., Foster City, California

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif